ORKAMBI is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Vertex Pharmaceuticals Incorporated. The primary component is Ivacaftor; Lumacaftor.
Product ID | 51167-122_2412d19f-9f31-49f3-a7f9-f44db330fcf7 |
NDC | 51167-122 |
Product Type | Human Prescription Drug |
Proprietary Name | ORKAMBI |
Generic Name | Lumacaftor And Ivacaftor |
Dosage Form | Granule |
Route of Administration | ORAL |
Marketing Start Date | 2022-09-02 |
Marketing Category | NDA / |
Application Number | NDA211358 |
Labeler Name | Vertex Pharmaceuticals Incorporated |
Substance Name | IVACAFTOR; LUMACAFTOR |
Active Ingredient Strength | 94 mg/1; mg/1 |
Pharm Classes | Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inducers [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-09-02 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
51167-122 | ORKAMBI | lumacaftor and ivacaftor |
51167-500 | ORKAMBI | lumacaftor and ivacaftor |
51167-700 | ORKAMBI | lumacaftor and ivacaftor |
51167-809 | ORKAMBI | lumacaftor and ivacaftor |
51167-900 | ORKAMBI | lumacaftor and ivacaftor |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ORKAMBI 86399751 4828608 Live/Registered |
Vertex Pharmaceuticals Incorporated 2014-09-19 |
ORKAMBI 86179790 4822946 Live/Registered |
Vertex Pharmaceuticals Incorporated 2014-01-30 |